J. Ferkany

发表

Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors.

J. Coyle, J. Lehmann, P. Schaefer, 1983, European journal of pharmacology.

Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine.

M. Pontecorvo, J. Witkin, P. Terry, 1993, The Journal of pharmacology and experimental therapeutics.

Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.

J. Coyle, J. Ferkany, R. Zaczek, 1983, Neurobehavioral toxicology and teratology.

Biochemical and behavioral studies following subchronic administration of GABA uptake inhibitors in mice

S. Enna, J. Ferkany, E. Karbon, 1991, Neuropharmacology.

Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents

M. Pontecorvo, R. Patch, J. Ferkany, 1991, Brain Research Bulletin.

Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

S. Snyder, J. Stewart, D. Manning, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Excitatory Amino Acid Receptors

J. Coyle, J. Ferkany, 1980 .

NPC 205 is a potent and selective adenosine A1, receptor antagonist: Correlation among receptor binding, biochemical, and physiological assays

J. Ferkany, J. Connor, R. Hicks, 1990 .

Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue.

M. Williams, M. Jarvis, J. Ferkany, 1987, Biochemical pharmacology.

Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists

M. Williams, J. Ferkany, G. Stone, 1986 .

Glutamate-containing dipeptides enhance specific binding at glutamate receptors and inhibit specific binding at kainate receptors in rat brain

J. Coyle, J. Ferkany, R. Zaczek, 1984, Neuroscience Letters.

Chapter 12 Radioreceptor Assays

S. Enna, J. Ferkany, 1982 .

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

L. Lesko, J. Ferkany, D. DeHaven-Hudkins, 1990, Pharmacology Biochemistry and Behavior.

Evidence for direct interactions between the NMDA and glycine recognition sites in brain.

J. Ferkany, P. Kaplita, 1990, European journal of pharmacology.

SYNTHESIS AND GLUTAMATE ANTAGONIST ACTIVITY OF 4-PHOSPHONOALKYLQUINOLINE DERIVATIVES : A NOVEL CLASS OF NON-NMDA ANTAGONIST

J. Ferkany, D. L. Bednar, E. Karbon, 1994 .

γ‐Aminobutyric AcidB Receptor Activation Modifies Agonist Binding to β‐Adrenergic Receptors in Rat Brain Cerebral Cortex

S. Enna, J. Ferkany, E. Karbon, 1989 .

Identification of phenobarbital N-glucosides as urinary metabolites of phenobarbital in mice.

J. Ferkany, W. Soine, P. Soine, 1991, Journal of pharmaceutical sciences.

Failure of folic acid derivatives to mimic the actions of kainic acid in brain in vitro or in vivo.

J. Coyle, J. Ferkany, J. Slevin, 1982, Neurobehavioral toxicology and teratology.

Dopamine Receptor Supersensitivity in the Corpus Striatum Following Chronic Elevation of Brain γ‐Aminobutyric Acid

R. Strong, S. Enna, J. Ferkany, 1980, Journal of neurochemistry.

Asymmetric synthesis of a potent and selective competitive NMDA antagonist

R. Patch, B. Narayanan, J. Ferkany, 1993 .

Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.

M. Pontecorvo, F. Tortella, J. Ferkany, 1988, Life sciences.

Development of rat brain uptake and calcium-dependent release of GABA

S. Enna, J. Ferkany, D. Redburn, 1978, Brain Research.

Footshock-induced freezing behavior in rats as a model for assessing anxiolytics

J. Ferkany, M. Abreu, L. Conti, 2005, Psychopharmacology.

Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids.

J. Coyle, J. Ferkany, 1983, The Journal of pharmacology and experimental therapeutics.

Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors

J. Coyle, J. Ferkany, R. Zaczek, 1982, Nature.

The dissociation of evoked release of [3H]-GABA and of endogenous GABA from chick retina in vitro.

P. Campochiaro, J. Coyle, J. Ferkany, 1984, Experimental eye research.

Pharmacological profile of novel cyclic analogs of 2-amino-7-phosphonoheptanoic acid.

R. Patch, B. Narayanan, J. Ferkany, 1992, Epilepsy research. Supplement.

Augmentation of neurotransmitter receptor-stimulated cyclic AMP accumulation in rat brain: differentiation between the effects of baclofen and phorbol esters

S. Enna, J. Ferkany, E. Karbon, 1988, Brain Research.

Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.

J. Ferkany, D. Mcpherson, L. Noronha-Blob, 1988, Journal of medicinal chemistry.

Properties of 3H-cimetidine binding in rat brain membrane fractions.

S. Enna, J. Ferkany, D. Kendall, 1980, Life sciences.

Heterogeneity of sodium‐dependent excitatory amino uptake mechanisms in rat brain

J. Coyle, J. Ferkany, 1986, Journal of neuroscience research.

Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention.

S. Enna, J. Ferkany, M. Cunningham, 1994, Life sciences.

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

A. Snowman, J. Collins, J. Ferkany, 1995, Psychopharmacology.

Measurement of gamma-aminobutyric acid (GABA) in blood.

R. Caprioli, S. Enna, J. Ferkany, 1978, Life sciences.

Biochemical identification of pharmacologically and functionally distinct GABA receptors in rat brain

S J Enna, M. Browner, S. Enna, 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Subcellular distribution of GABA receptors in bovine retina.

J. Ferkany, D. Redburn, C. Kyles, 1979, Experimental eye research.

Excitatory amino acid analogs evoke release of endogenous amino acids and acetyl choline from chick retina in vitro

P. Campochiaro, J. Coyle, J. Ferkany, 1985, Vision Research.

Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.

D. R. Curtis, P. Krogsgaard‐Larsen, N. Diemer, 1991, Journal of medicinal chemistry.

Novel Class of Amino Acid Antagonists at Non‐N‐methyl‐D‐aspartic Acid Excitatory Amino Acid Receptors. Synthesis, in vitro and in vivo Pharmacology, and Neuroprotection.

D. R. Curtis, P. Krogsgaard‐Larsen, N. Diemer, 1991 .

Dextromethorphan inhibits NMDA-induced convulsions.

M. Pontecorvo, J. Ferkany, D. Clissold, 1988, European journal of pharmacology.

Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron.

J. Coyle, J. Lehmann, J. Ferkany, 1985, The Journal of pharmacology and experimental therapeutics.

EFFECT OF DRUGS ON RAT BRAIN, CEREBROSPINAL FLUID AND BLOOD GABA CONTENT

J. Ferkany, I. Butler, S. Enna, 1979, Journal of Neurochemistry.

NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.

P. Krogsgaard‐Larsen, J. Ferkany, U. Madsen, 1990, European journal of pharmacology.

Neurochemical Analysis of Rat Cisternal Cerebrospinal Fluid

J. Ferkany, I. Butler, S. Enna, 1983 .

Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.

L. Snell, Susan M. Jones, J. Ferkany, 1989, The Journal of pharmacology and experimental therapeutics.

Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.

J. Ferkany, D. Clissold, G. S. Hamilton, 1993, The Journal of pharmacology and experimental therapeutics.

Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.

R. Patch, J. Ferkany, D. L. Bednar, 1993, The Journal of pharmacology and experimental therapeutics.

Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist.

G. Pasternak, J. Ferkany, Y. Kolesnikov, 1993, Life sciences.

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

J. Ferkany, M. Abreu, E. French, 1991, Neuropharmacology.

Ifenprodil potently interacts with [3H](+)-3-PPP-labeled sigma binding sites in guinea pig brain membranes.

M. Pontecorvo, R. Patch, J. Ferkany, 1990, European journal of pharmacology.

N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine.

M. Pontecorvo, J. Ferkany, D. Clissold, 1991, Behavioral neuroscience.

The mechanism of kainic acid neurotoxicity

J. Coyle, J. Ferkany, R. Zaczek, 1984, Nature.

Pharmacology of (2R, 4R, 5S)-2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid (NPC 17742); a selective, systemically active, competitive NMDA antagonist

J. Ferkany, G. S. Hamilton, J. Willetts, 1993 .

Enzymatic asymmetric synthesis of (2R, 4R, 5S)-2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid, a potent, selective and competitive NMDA antagonist

R. Patch, B. Narayanan, J. Ferkany, 1993 .

Evoked release of aspartate and glutamate: disparities between prelabeling and direct measurement

J. Coyle, J. Ferkany, 1983, Brain Research.

Evidence for pharmacologically distinct subsets of GABAB receptors

S. Enna, J. Ferkany, R. W. Scherer, 1988, Brain Research Bulletin.

Chronology of neurochemical alterations induced by GABA agonist administration.

S. Enna, J. Ferkany, I. Butler, 1981, Advances in biochemical psychopharmacology.

The Envelope Glycoprotein of HIV‐1 Alters NMDA Receptor Function

J. Wroblewski, J. Ferkany, E. Karbon, 1993, The European journal of neuroscience.

Characterization of Wild‐Type Excitatory Amino Acid Ion Channel Receptors

J. Ferkany, 1999 .

Neurochemical effects of kojic amine, a gabamimetic, and its interaction with benzylamine oxidase

S. Enna, J. Ferkany, T. Andree, 1981, Neuropharmacology.

Competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists, haloperidol, and scopolamine impair performance in a nonspatial operant discrimination task

M. Pontecorvo, J. Ferkany, D. Clissold, 1991, Psychobiology.

Specific binding of [3H]+/- 2-amino-7-phosphono heptanoic acid to rat brain membranes in vitro.

J. Coyle, J. Ferkany, 1983, Life Science.

Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatum.

S. Enna, J. Ferkany, 1980, Life Science.

Phosphonoethylphenylalanine derivatives as novel antagonists of non-NMDA ionotropic glutamate receptors

R. Patch, J. Ferkany, D. L. Bednar, 1992 .

Effects of strychnine-insensitive glycine receptor antagonists and sigma agents on working memory performance: comparison with dizocilpine and scopolamine.

M. Pontecorvo, J. Ferkany, E. Karbon, 1992, Behavioural pharmacology.

Excitatory Amino Acid Receptor Interactions of a Novel α-Phosphinic Acid Analogue of α-Methylaspartic Acid

J. Coyle, J. Lehmann, J. Ferkany, 1984 .